Determining the Role of the Gut Microbiome in Melanoma Treated With Anti–PD-1 ICIs

11:58 EDT 6 Jun 2018 | Cancer Networks

Jun 6, 2018

Patients who responded to anti–PD-1 therapy and experienced prolonged progression-free survival had a much greater diversity of gut bacteria.

More From BioPortfolio on "Determining the Role of the Gut Microbiome in Melanoma Treated With Anti–PD-1 ICIs"